Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

422
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
422
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

916
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
916
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

417
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
417
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

419
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
419
Oogenesis02:07

Oogenesis

69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy.

Molecules (Basel, Switzerland)·2021
Same author

Case Report: Pink Urine Syndrome Following Exposure to Propofol: A Rare, Impressive but Benign Complication.

Frontiers in pharmacology·2021
Same author

TMT-based quantitative proteomic analysis of the effects of Pseudomonas syringae pv. tabaci (Pst) infection on photosynthetic function and the response of the MAPK signaling pathway in tobacco leaves.

Plant physiology and biochemistry : PPB·2021
Same author

Peritumoral Microgel Reservoir for Long-Term Light-Controlled Triple-Synergistic Treatment of Osteosarcoma with Single Ultra-Low Dose.

Small (Weinheim an der Bergstrasse, Germany)·2021
Same author

Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway.

Journal of cellular and molecular medicine·2021
Same author

PSSP-MVIRT: peptide secondary structure prediction based on a multi-view deep learning architecture.

Briefings in bioinformatics·2021

Related Experiment Video

Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K

Orlistat impairs Chlamydia trachomatis development by disrupting its developmental cycle.

Jingpin Gao1, Mingxin Jiang1, Jianlin Chen1

  • 1Reproductive Medicine Center, Department of Gynecology and Obstetrics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Microbial Pathogenesis
|January 13, 2026
PubMed
Summary

Orlistat, a weight-loss drug, disrupts the developmental cycle of Chlamydia trachomatis, a common bacterial STI. This finding offers a potential new strategy for treating chlamydial infections where standard antibiotics fail.

Keywords:
Chlamydia trachomatisLipid metabolismOrlistat

More Related Videos

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

Related Experiment Videos

Last Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

Area of Science:

  • Bacteriology
  • Microbial Pathogenesis
  • Drug Discovery

Background:

  • Chlamydia trachomatis is a prevalent sexually transmitted bacterium causing urogenital infections.
  • Infections can lead to chronic inflammation and fibrosis due to asymptomatic progression.
  • Current treatments like azithromycin and doxycycline face documented therapeutic failures.

Purpose of the Study:

  • To investigate the potential of orlistat in disrupting the Chlamydia trachomatis developmental cycle.
  • To evaluate orlistat's efficacy against chlamydial infection in vitro and in vivo.

Main Methods:

  • In vitro and in vivo models were used to assess orlistat's effect on Chlamydia trachomatis.
  • Transcriptomic analysis was employed to understand the impact on gene expression during infection.

Main Results:

  • Orlistat demonstrated inhibition of early chlamydial infection stages.
  • The drug interfered with reticulate body replication and differentiation into elementary bodies.
  • Transcriptomic data showed downregulation of genes crucial for mid-to-late chlamydial development.

Conclusions:

  • Orlistat disrupts the Chlamydia trachomatis developmental cycle.
  • The findings suggest orlistat as a potential therapeutic agent against chlamydial infections, particularly those resistant to conventional antibiotics.
  • Further research is needed to fully elucidate the mechanisms of orlistat's action against Chlamydia trachomatis.